Today, Embla Medical’s CEO, Sveinn Sölvason, presented the Q3 2026 results and the key drivers behind them, and outlined the reasoning for the narrowing of the full-year 2026 guidance. The presentation was followed by a Q&A session
You can watch a recording of the presentation here:
Embla Medical - Q2 2026 Presentation
Disclaimer: HC Andersen Capital receives payment from Embla Medical for a Digital IR subscription agreement. /Victor Skriver, 16:50 20/10-2026